Psychedelic Therapy—A New Paradigm of Care for Mental Health

R Yehuda, A Lehrner - JAMA, 2023 - jamanetwork.com
Currently, most psychedelic compounds are illegal under federal law. They were placed on
the most restrictive class of drugs, Schedule I, in the 1970s as part of the “war on drugs,” …

Should Australian psychology consider enhancing psychotherapeutic interventions with psychedelic drugs? A call for research

S Bright, M Williams - Australian Psychologist, 2018 - Taylor & Francis
International research is increasingly demonstrating that psychedelic‐assisted
psychotherapy can enhance psychotherapeutic outcomes and be effective for some …

Ethical issues regarding nonsubjective psychedelics as standard of care

DB Yaden, BD Earp, RR Griffiths - Cambridge Quarterly of Healthcare …, 2022 - cambridge.org
Evidence suggests that psychedelics bring about their therapeutic outcomes in part through
the subjective or qualitative effects they engender and how the individual interprets the …

Optimizing real-world benefit and risk of new psychedelic medications: the need for innovative postmarket surveillance

JC Black, AA Monte, N Dasgupta, JS Jewell… - Nature Mental …, 2024 - nature.com
The encouraging results of late-phase clinical trials investigating psychedelic-assisted
psychotherapy suggests that US Food and Drug Administration approval and subsequent …

[HTML][HTML] New frontiers or a bursting bubble? Psychedelic therapy beyond the dichotomy

T Noorani, J Martell - Frontiers in Psychiatry, 2021 - frontiersin.org
The publication in April 2021 of the Imperial College London Phase II study investigating the
efficacy of psilocybin-assisted therapy vs. escitalopram for depression reported differences …

An assessment of psychedelic knowledge among people using psychedelics naturalistically

DJ Kruger, NG Glynos, CW Fields… - Journal of …, 2023 - Taylor & Francis
Identifying gaps and strengths in psychedelic-related knowledge is key to developing
effective, evidence-based education to inform appropriate use of and harm reduction …

From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide

DE Smith, GE Raswyck… - Journal of Psychoactive …, 2014 - Taylor & Francis
Since the discovery of its psychedelic properties in 1943, lysergic acid diethylamide (LSD)
has been explored by psychiatric/therapeutic researchers, military/intelligence agencies …

Containment matters: set and setting in contemporary psychedelic psychiatry

T Noorani - Philosophy, Psychiatry, & Psychology, 2021 - muse.jhu.edu
Over the past decade and a half, psychedelic drug-induced experiences have been
returning to psychiatry as promising new healing modalities. The case of psychedelic …

Psychedelics to Relieve Psychological Suffering Associated with a Life-Threatening Diagnosis: Time for a Canadian Policy Discussion.

S Kratina, C Lo, C Strike, R Schwartz… - Healthcare …, 2023 - search.ebscohost.com
In Canada, the conversation to enable access to therapeutic psychedelics is under way.
With recent federal initiatives, Canadians can request access to psychedelic-assisted …

Psychedelics as reemerging treatments for anxiety disorders: possibilities and challenges in a nascent field

F King IV, R Hammond - Focus, 2021 - Am Psychiatric Assoc
Although psychedelics initially showed promise in treating anxiety disorders, psychedelics
were criminalized and research halted in the early 1970s. A subsequent resurgence of …